Pittenger & Anderson Inc’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-60
Closed -$3K – 464
2021
Q3
$3K Hold
60
– – ﹤0.01% 412
2021
Q2
$3K Buy
60
+10
+20% +$533 ﹤0.01% 377
2021
Q1
$2K Buy
50
+23
+85% +$1.11K ﹤0.01% 377
2020
Q4
$1K Buy
+27
New +$996 ﹤0.01% 365

Other funds holding HCAT

Pittenger & Anderson Inc's HCAT Position: Q4 2021 in Review

Pittenger & Anderson Inc sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 60 shares — an estimated $3K sold.

Pittenger & Anderson Inc first reported a position in HCAT in Q4 2020 and held it in 4 quarters. The position peaked at $3K in Q3 2021. 187 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

  • Pittenger & Anderson Inc reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 60 Health Catalyst shares in Q4 2021, an estimated $3K.
  • Pittenger & Anderson Inc first reported a position in Health Catalyst in Q4 2020 and held it in 4 quarters.
  • Pittenger & Anderson Inc's Health Catalyst position peaked at $3K in Q3 2021.
  • 187 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2021, filed 10 Feb 2022.